EnGeneIC Competitors and Similar CompaniesClear all
EnGeneIC's competitors and similar companies include Genelux, SOTIO and Elpis Biopharmaceuticals.
 EnGeneIC EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV nanocell platform. |  Genelux Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform. |  Elpis Biopharmaceuticals Elpis Biopharmaceuticals is a company developing biological and cellular therapeutics for difficult-to-treat cancers. | ||
Founding Date | Founding Date 2001 | Founding Date 2001 | Founding Date 2010 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Lane Cove West, AU HQ New York, US | Locations Thousand Oaks, US HQ | Locations CZ HQ Moskva, RU Basel, CH Boston, US | Locations Lexington, US HQ |
Employees | Employees 43 | Employees 157% increase | Employees 218 | Employees 12 |
Funding | ||||
Latest funding round | Latest funding round $ 150k (about 9 years ago) | Latest funding round N/A | Latest funding round $ 300k (about 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 21.1m | Total funding raised N/A | Total funding raised $ 300k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Genelux
HQ
Thousand Oaks, US
Employees
15↑ 7% increase
Genelux is a clinical-stage biopharmaceutical company developing an oncolytic virus-based technology platform.
View company
SOTIO
HQ
CZ
Employees
218
SOTIO is a biotechnology company that develops therapies focusing on the treatment of cancer.
View companyElpis Biopharmaceuticals
HQ
Lexington, US
Employees
12
Elpis Biopharmaceuticals is a company developing biological and cellular therapeutics for difficult-to-treat cancers.
View company